Income Statement Intuitive Surgical, Inc.

Equities

ISRG

US46120E6023

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 01:30:00 16/05/2026 am IST			After hours 02:05:14 am
421.12 ^USD	-1.62%		425.31	+0.99%

11:44pm	West Pharma says operations recovering after cyberattack	RE
30/04	Intuitive Surgical Insider Sold Shares Worth $291,887, According to a Recent SEC Filing	MT

308da62da2d70dfb71b90724.l_2BjptuxZuj7nKkKTRO_Qzv6aFsbLWTSwbs5q7qVfY.uoXHvPEEl8LnpAH9c2EAxWSF0PEEAPymCm-7vMy-BKWuk9jHqz6LtvKhFQ

Published financial data: INTUITIVE SURGICAL, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	571.01Cr	622.22Cr	712.41Cr	835.21Cr	1.01TCr
Total Revenues	571.01Cr	622.22Cr	712.41Cr	835.21Cr	1.01TCr
Cost of Goods Sold, Total	175.16Cr	202.62Cr	239.46Cr	271.79Cr	342.24Cr
Gross Profit	395.85Cr	419.6Cr	472.95Cr	563.42Cr	664.23Cr
Selling General & Admin Expenses, Total	146.65Cr	171.18Cr	196.39Cr	211.88Cr	238.5Cr
R&D Expenses	67Cr	88Cr	100Cr	114.53Cr	131.18Cr
Other Operating Expenses, Total	213.75Cr	259.08Cr	296.27Cr	326.41Cr	369.68Cr
Operating Income	182.1Cr	160.52Cr	176.68Cr	237.01Cr	294.55Cr
Interest And Investment Income	8.08Cr	11Cr	20Cr	34Cr	38Cr
Net Interest Expenses	8.08Cr	11Cr	20Cr	34Cr	38Cr
Currency Exchange Gains (Loss)	-9L	-2.73Cr	-37L	-27L	-1.3Cr
EBT, Excl. Unusual Items	190.09Cr	168.39Cr	196.62Cr	270.43Cr	331.34Cr
Gain (Loss) On Sale Of Investments	-1.06Cr	-4.9Cr	-73L	-93L	-20L
Legal Settlements	-	-2.81Cr	-	-2.12Cr	-
EBT, Incl. Unusual Items	189.03Cr	160.68Cr	195.89Cr	267.38Cr	331.14Cr
Income Tax Expense	16Cr	26Cr	14Cr	34Cr	43Cr
Earnings From Continuing Operations	172.81Cr	134.44Cr	181.73Cr	233.75Cr	287.66Cr
Net Income to Company	172.81Cr	134.44Cr	181.73Cr	233.75Cr	287.66Cr
Minority Interest	-2.35Cr	-2.21Cr	-1.93Cr	-1.49Cr	-2.06Cr
Net Income - (IS)	170.46Cr	132.23Cr	179.8Cr	232.26Cr	285.6Cr
Net Income to Common Incl Extra Items	170.46Cr	132.23Cr	179.8Cr	232.26Cr	285.6Cr
Net Income to Common Excl. Extra Items	170.46Cr	132.23Cr	179.8Cr	232.26Cr	285.6Cr
Per Share Items
Net EPS - Basic	4.79	3.72	5.12	6.54	8
Basic EPS - Continuing Operations	4.79	3.72	5.12	6.54	8
Basic Weighted Average Shares Outstanding	36Cr	36Cr	35Cr	36Cr	36Cr
Net EPS - Diluted	4.66	3.65	5.03	6.42	7.87
Diluted EPS - Continuing Operations	4.66	3.65	5.03	6.42	7.87
Diluted Weighted Average Shares Outstanding	37Cr	36Cr	36Cr	36Cr	36Cr
Normalized Basic EPS	3.27	2.9	3.44	4.72	5.74
Normalized Diluted EPS	3.18	2.85	3.38	4.63	5.65
American Depositary Receipts Ratio (ADR)	0.1	0.1	0.1	0.1	0.1
Supplemental Items
EBITDA	212.84Cr	195.9Cr	216.9Cr	282.58Cr	355.8Cr
EBITA	184.84Cr	163.3Cr	178.7Cr	238.68Cr	295.87Cr
EBIT	182.1Cr	160.52Cr	176.68Cr	237.01Cr	294.55Cr
EBITDAR	214.88Cr	198.47Cr	219.58Cr	285.97Cr	359.89Cr
Total Revenues (As Reported)	571.01Cr	622.22Cr	712.41Cr	835.21Cr	1.01TCr
Effective Tax Rate - (Ratio)	8.58	16.33	7.23	12.58	13.13
Current Domestic Taxes	18Cr	40Cr	35Cr	37Cr	29Cr
Current Foreign Taxes	5.01Cr	4.81Cr	7.44Cr	10Cr	12Cr
Total Current Taxes	23Cr	45Cr	42Cr	47Cr	42Cr
Deferred Domestic Taxes	-2.09Cr	-21Cr	-15Cr	-18Cr	-4.92Cr
Deferred Foreign Taxes	-4.31Cr	1.99Cr	-13Cr	4.63Cr	6.83Cr
Total Deferred Taxes	-6.4Cr	-19Cr	-28Cr	-14Cr	1.91Cr
Normalized Net Income	116.46Cr	103.03Cr	120.96Cr	167.53Cr	205.03Cr
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	67Cr	88Cr	100Cr	114.53Cr	131.18Cr
Net Rental Expense, Total	2.04Cr	2.57Cr	2.68Cr	3.39Cr	4.09Cr
Stock-Based Comp., COGS (Total)	9.11Cr	9.12Cr	11Cr	13Cr	16Cr
Stock-Based Comp., R&D Exp. (Total)	13Cr	16Cr	21Cr	25Cr	30Cr
Stock-Based Comp., SG&A Exp. (Total)	23Cr	26Cr	27Cr	30Cr	35Cr
Total Stock-Based Compensation	46Cr	52Cr	60Cr	69Cr	80Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	129.09Cr	158.12Cr	275.01Cr	202.74Cr	336.8Cr
Short Term Investments	294Cr	254.1Cr	247.31Cr	198.59Cr	256.69Cr
Total Cash And Short Term Investments	423.09Cr	412.22Cr	522.32Cr	401.33Cr	593.49Cr
Accounts Receivable, Total	89Cr	107.33Cr	126.75Cr	135.68Cr	162.82Cr
Total Receivables	89Cr	107.33Cr	126.75Cr	135.68Cr	162.82Cr
Inventory	59Cr	89Cr	122.06Cr	148.72Cr	184Cr
Prepaid Expenses	13Cr	16Cr	17Cr	25Cr	38Cr
Other Current Assets, Total	-	-	81L	-	-
Total Current Assets	584.49Cr	625.3Cr	788.8Cr	711.1Cr	977.95Cr
Gross Property Plant And Equipment	291.94Cr	369.43Cr	517.89Cr	666.43Cr	776.97Cr
Accumulated Depreciation	-97Cr	-123.79Cr	-156.2Cr	-188.13Cr	-227.65Cr
Net Property Plant And Equipment	195.08Cr	245.64Cr	361.69Cr	478.3Cr	549.32Cr
Long-term Investments	443.11Cr	268.27Cr	219.45Cr	490.37Cr	322.09Cr
Goodwill	34Cr	35Cr	35Cr	35Cr	37Cr
Other Intangibles, Total	7.05Cr	4.98Cr	3.91Cr	2.3Cr	1.71Cr
Accounts Receivable Long-Term	28Cr	30Cr	23Cr	25Cr	20Cr
Deferred Tax Assets Long-Term	44Cr	66Cr	91Cr	104.51Cr	101.86Cr
Deferred Charges Long-Term	7.18Cr	7.23Cr	8.93Cr	15Cr	18Cr
Other Long-Term Assets, Total	12Cr	15Cr	12Cr	14Cr	18Cr
Total Assets	1.36TCr	1.3TCr	1.54TCr	1.87TCr	2.05TCr
Liabilities
Accounts Payable, Total	12Cr	15Cr	19Cr	19Cr	26Cr
Accrued Expenses, Total	56Cr	67Cr	74Cr	84Cr	102.17Cr
Current Portion of Leases	2.04Cr	2.57Cr	2.53Cr	3.35Cr	3.9Cr
Current Income Taxes Payable	5.41Cr	9.61Cr	11Cr	15Cr	13Cr
Unearned Revenue Current, Total	38Cr	40Cr	45Cr	47Cr	51Cr
Other Current Liabilities	1.2Cr	8.11Cr	14Cr	5.72Cr	5.83Cr
Total Current Liabilities	114.98Cr	142.21Cr	165.87Cr	174.53Cr	200.62Cr
Long-Term Leases	6.66Cr	6.96Cr	6.45Cr	11Cr	13Cr
Unearned Revenue Non Current	3.68Cr	4.1Cr	4.56Cr	5.41Cr	9.14Cr
Other Non Current Liabilities	35Cr	33Cr	28Cr	30Cr	29Cr
Total Liabilities	160.35Cr	186.14Cr	204.42Cr	221.36Cr	251.7Cr
Common Stock, Total	4L	4L	4L	4L	4L
Additional Paid In Capital	716.4Cr	770.39Cr	857.64Cr	968.13Cr	1.08TCr
Retained Earnings	476.09Cr	350.01Cr	474.3Cr	680.33Cr	701.18Cr
Comprehensive Income and Other	-2.42Cr	-16Cr	-1.22Cr	-5.13Cr	4.33Cr
Total Common Equity	1.19TCr	1.1TCr	1.33TCr	1.64TCr	1.78TCr
Minority Interest	5.04Cr	7.07Cr	8.97Cr	9.59Cr	12Cr
Total Equity	1.2TCr	1.11TCr	1.34TCr	1.65TCr	1.79TCr
Total Liabilities And Equity	1.36TCr	1.3TCr	1.54TCr	1.87TCr	2.05TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	36Cr	35Cr	35Cr	36Cr	36Cr
ECS Total Common Shares Outstanding	36Cr	35Cr	35Cr	36Cr	36Cr
Book Value / Share	33.27	31.55	37.77	46.08	50.19
Tangible Book Value	1.15TCr	1.06TCr	1.29TCr	1.61TCr	1.74TCr
Tangible Book Value Per Share	32.11	30.41	36.67	45.05	49.1
Total Debt	8.7Cr	9.53Cr	8.98Cr	15Cr	17Cr
Net Debt	-414.39Cr	-402.69Cr	-513.34Cr	-386.73Cr	-576.4Cr
Debt Equivalent Oper. Leases	16Cr	21Cr	21Cr	27Cr	33Cr
Minority Interest, Total (Incl. Fin. Div)	5.04Cr	7.07Cr	8.97Cr	9.59Cr	12Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	21Cr	38Cr	45Cr	56Cr	56Cr
Inventories - Work In Process, Total	9.64Cr	16Cr	16Cr	21Cr	29Cr
Inventories - Finished Goods, Total	28Cr	35Cr	61Cr	72Cr	99Cr
Land - (BS)	37Cr	39Cr	46Cr	48Cr	48Cr
Buildings, Total	81Cr	87Cr	100.21Cr	148.63Cr	283.39Cr
Machinery, Total	62Cr	70Cr	88Cr	107.08Cr	127.13Cr
Full Time Employees	9.79T	12.12T	13.68T	15.64T	17.02T
Assets on Operating Lease - Gross	62Cr	81Cr	114.97Cr	157.91Cr	209.66Cr
Assets on Operating Lease - Accumulated Depreciation	-18Cr	-29Cr	-43Cr	-57Cr	-73Cr
Accumulated Allowance for Doubtful Accounts (Supple)	71L	79L	1.01Cr	2L	32L

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	170.46Cr	132.23Cr	179.8Cr	232.26Cr	285.6Cr
Depreciation & Amortization - CF	28Cr	33Cr	38Cr	44Cr	60Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.74Cr	2.78Cr	2.02Cr	1.67Cr	1.32Cr
Depreciation & Amortization, Total	31Cr	35Cr	40Cr	46Cr	61Cr
Amortization of Deferred Charges, Total - (CF)	2.2Cr	2.66Cr	3.3Cr	3.77Cr	4.99Cr
(Gain) Loss From Sale Of Asset	28L	82L	1.96Cr	52L	1.37Cr
(Gain) Loss on Sale of Investments - (CF)	1.06Cr	4.9Cr	73L	-4.33Cr	-5.72Cr
Stock-Based Compensation (CF)	45Cr	51Cr	59Cr	68Cr	79Cr
Tax Benefit from Stock Options	-	-	-	-	-
Other Operating Activities, Total	-3.91Cr	-16Cr	-26Cr	-12Cr	3.97Cr
Change In Accounts Receivable	-14Cr	-16Cr	-19Cr	-9.59Cr	-30Cr
Change In Inventories	-26Cr	-55Cr	-71Cr	-83Cr	-106.34Cr
Change In Accounts Payable	3.6Cr	2.13Cr	4.17Cr	-4L	5.79Cr
Change in Unearned Revenues	3.26Cr	2.15Cr	5.34Cr	3.12Cr	7.52Cr
Change in Other Net Operating Assets	-3.84Cr	4.4Cr	2.61Cr	-2.42Cr	-4.03Cr
Cash from Operations	208.94Cr	149.08Cr	181.38Cr	241.5Cr	303.05Cr
Capital Expenditure	-35Cr	-53Cr	-106.42Cr	-111.12Cr	-54Cr
Cash Acquisitions	-87L	-1.28Cr	-89L	-10L	-1.39Cr
Investment in Marketable and Equity Securities, Total	-209.93Cr	191.6Cr	71Cr	-216.06Cr	121.95Cr
Cash from Investing	-246.15Cr	137.08Cr	-36Cr	-327.28Cr	67Cr
Issuance of Common Stock	28Cr	23Cr	30Cr	43Cr	35Cr
Repurchase of Common Stock	-21Cr	-280.16Cr	-58Cr	-27Cr	-271.44Cr
Other Financing Activities, Total	-2.19Cr	-45L	-29L	-85L	-
Cash from Financing	4.3Cr	-257.23Cr	-29Cr	15Cr	-236.41Cr
Foreign Exchange Rate Adjustments	-34L	54L	33L	-8L	1.28Cr
Net Change in Cash	-33Cr	29Cr	116.94Cr	-71Cr	134.5Cr
Supplemental Items
Cash Income Tax Paid (Refund)	18Cr	44Cr	45Cr	47Cr	54Cr
Levered Free Cash Flow	159.73Cr	111.8Cr	78Cr	119.71Cr	227.48Cr
Unlevered Free Cash Flow	159.73Cr	111.8Cr	78Cr	119.71Cr	227.48Cr
Change In Net Working Capital	-2.65Cr	25Cr	29Cr	35Cr	49Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	9.21	7.56	7.77	8.67	9.39
Return on Total Capital	10.4	8.63	8.94	9.82	10.58
Return On Equity %	15.92	11.66	14.83	15.62	16.69
Return on Common Equity	15.76	11.53	14.77	15.62	16.67
Margin Analysis
Gross Profit Margin %	69.32	67.44	66.39	67.46	66
SG&A Margin	25.68	27.51	27.57	25.37	23.7
EBITDA Margin %	37.27	31.48	30.45	33.83	35.35
EBITA Margin %	32.37	26.24	25.08	28.58	29.4
EBIT Margin %	31.89	25.8	24.8	28.38	29.27
Income From Continuing Operations Margin %	30.26	21.61	25.51	27.99	28.58
Net Income Margin %	29.85	21.25	25.24	27.81	28.38
Net Avail. For Common Margin %	29.85	21.25	25.24	27.81	28.38
Normalized Net Income Margin	20.39	16.56	16.98	20.06	20.37
Levered Free Cash Flow Margin	27.97	17.97	10.94	14.33	22.6
Unlevered Free Cash Flow Margin	27.97	17.97	10.94	14.33	22.6
Asset Turnover
Asset Turnover	0.46	0.47	0.5	0.49	0.51
Fixed Assets Turnover	3.18	2.82	2.35	1.99	1.96
Receivables Turnover (Average Receivables)	7.05	6.33	6.09	6.37	6.74
Inventory Turnover (Average Inventory)	2.95	2.74	2.27	2.01	2.06
Short Term Liquidity
Current Ratio	5.08	4.4	4.76	4.07	4.87
Quick Ratio	4.46	3.65	3.91	3.08	3.77
Operating Cash Flow to Current Liabilities	1.82	1.05	1.09	1.38	1.51
Days Sales Outstanding (Average Receivables)	51.76	57.67	59.96	57.5	54.13
Days Outstanding Inventory (Average Inventory)	123.84	133.33	161.1	182.32	177.42
Average Days Payable Outstanding	21.3	20.99	22.51	23.43	21.68
Cash Conversion Cycle (Average Days)	154.3	170.02	198.56	216.39	209.87
Long Term Solvency
Total Debt/Equity	0.73	0.86	0.67	0.88	0.95
Total Debt / Total Capital	0.72	0.85	0.67	0.88	0.94
LT Debt/Equity	0.56	0.63	0.48	0.68	0.74
Long-Term Debt / Total Capital	0.55	0.62	0.48	0.67	0.73
Total Liabilities / Total Assets	11.83	14.35	13.24	11.81	12.3
Total Debt / EBITDA	0.04	0.05	0.04	0.05	0.05
Net Debt / EBITDA	-1.93	-2.03	-2.34	-1.35	-1.6
Total Debt / (EBITDA - Capex)	0.05	0.07	0.08	0.08	0.06
Net Debt / (EBITDA - Capex)	-2.31	-2.77	-4.54	-2.21	-1.88
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	31.01	8.97	14.49	17.24	20.5
Gross Profit, 1 Yr. Growth %	38.35	6	12.71	19.13	17.89
EBITDA, 1 Yr. Growth %	61.17	-7.96	10.72	30.28	26.86
EBITA, 1 Yr. Growth %	68.1	-11.65	9.43	33.56	25.07
EBIT, 1 Yr. Growth %	73.46	-11.85	10.07	34.15	25.4
Earnings From Cont. Operations, 1 Yr. Growth %	61.99	-22.2	35.18	28.62	23.06
Net Income, 1 Yr. Growth %	60.72	-22.43	35.98	29.18	22.97
Normalized Net Income, 1 Yr. Growth %	63.16	-11.53	17.4	39.03	23.79
Diluted EPS Before Extra, 1 Yr. Growth %	58.5	-21.67	37.81	27.63	22.59
Accounts Receivable, 1 Yr. Growth %	22.9	20.19	18.09	7.05	20
Inventory, 1 Yr. Growth %	-2.39	52.14	36.65	21.84	23.72
Net Property, Plant and Equip., 1 Yr. Growth %	18.86	25.92	47.24	32.24	14.85
Total Assets, 1 Yr. Growth %	21.36	-4.29	19.02	21.38	9.15
Tangible Book Value, 1 Yr. Growth %	23.29	-7.34	21.39	24.33	8.55
Common Equity, 1 Yr. Growth %	22.29	-7.22	20.52	23.49	8.46
Cash From Operations, 1 Yr. Growth %	40.72	-28.65	21.67	33.15	25.49
Capital Expenditures, 1 Yr. Growth %	3.51	56.82	99.89	4.42	-51.42
Levered Free Cash Flow, 1 Yr. Growth %	77.32	-30.62	-30.12	53.62	92.15
Unlevered Free Cash Flow, 1 Yr. Growth %	77.32	-30.62	-30.12	53.62	92.15
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.92	19.48	11.7	15.86	18.86
Gross Profit, 2 Yr. CAGR %	12.82	21.1	9.31	15.88	18.51
EBITDA, 2 Yr. CAGR %	16.27	21.8	0.95	20.1	28.08
EBITA, 2 Yr. CAGR %	14.19	21.86	-1.67	20.9	28.67
EBIT, 2 Yr. CAGR %	15.1	23.65	-1.5	21.51	29.12
Earnings From Cont. Operations, 2 Yr. CAGR %	11.83	12.26	2.55	31.86	25.81
Net Income, 2 Yr. CAGR %	11.17	11.66	2.7	32.53	26.03
Normalized Net Income, 2 Yr. CAGR %	11.74	20.15	1.91	28.61	30.44
Diluted EPS Before Extra, 2 Yr. CAGR %	10.02	11.42	3.89	32.62	25.08
Accounts Receivable, 2 Yr. CAGR %	12.28	21.54	19.14	12.43	13.34
Inventory, 2 Yr. CAGR %	-0.71	21.86	44.19	29.04	22.78
Net Property, Plant and Equip., 2 Yr. CAGR %	23.8	22.34	36.16	39.54	23.24
Total Assets, 2 Yr. CAGR %	18.01	7.78	6.73	20.19	15.1
Tangible Book Value, 2 Yr. CAGR %	21.01	6.88	6.05	22.85	16.17
Common Equity, 2 Yr. CAGR %	20.01	6.52	5.74	22	15.73
Cash From Operations, 2 Yr. CAGR %	14.34	0.2	-6.83	27.28	29.26
Capital Expenditures, 2 Yr. CAGR %	-8.86	24.86	77.05	44.47	-28.78
Levered Free Cash Flow, 2 Yr. CAGR %	24.94	11.4	-30.46	3.61	70.86
Unlevered Free Cash Flow, 2 Yr. CAGR %	24.94	11.4	-30.46	3.61	70.86
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	15.31	11.58	17.8	13.51	17.39
Gross Profit, 3 Yr. CAGR %	14.98	10.5	18.24	12.49	16.55
EBITDA, 3 Yr. CAGR %	15.97	7.56	17.99	9.91	22.01
EBITA, 3 Yr. CAGR %	13.66	4.83	17.57	8.89	21.91
EBIT, 3 Yr. CAGR %	13.53	5.31	18.95	9.18	22.43
Earnings From Cont. Operations, 3 Yr. CAGR %	15.38	-0.91	19.43	10.59	28.86
Net Income, 3 Yr. CAGR %	14.76	-1.4	19.24	10.86	29.26
Normalized Net Income, 3 Yr. CAGR %	11.86	3.38	19.22	12.89	26.5
Diluted EPS Before Extra, 3 Yr. CAGR %	13.78	-1.76	19.6	11.27	29.19
Accounts Receivable, 3 Yr. CAGR %	6.78	14.86	20.38	14.96	14.9
Inventory, 3 Yr. CAGR %	12.81	14.47	26.6	36.32	27.24
Net Property, Plant and Equip., 3 Yr. CAGR %	33.93	24.5	30.13	34.84	30.77
Total Assets, 3 Yr. CAGR %	19.99	10.05	11.4	11.41	16.4
Tangible Book Value, 3 Yr. CAGR %	21.71	10.71	11.51	11.83	17.88
Common Equity, 3 Yr. CAGR %	21.24	10.14	11	11.36	17.31
Cash From Operations, 3 Yr. CAGR %	21.34	-2.29	6.9	4.95	26.68
Capital Expenditures, 3 Yr. CAGR %	23.56	7.75	46.06	48.47	0.46
Levered Free Cash Flow, 3 Yr. CAGR %	30.44	2.99	-4.72	-9.43	26.83
Unlevered Free Cash Flow, 3 Yr. CAGR %	30.44	2.99	-4.72	-9.43	26.83
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.1	14.67	13.85	13.27	18.22
Gross Profit, 5 Yr. CAGR %	15.9	13.76	12.68	12.62	18.35
EBITDA, 5 Yr. CAGR %	15.16	11.09	9.71	12.41	21.92
EBITA, 5 Yr. CAGR %	13.53	8.71	7.26	10.98	21.89
EBIT, 5 Yr. CAGR %	13.62	8.59	7.26	11.51	22.92
Earnings From Cont. Operations, 5 Yr. CAGR %	18.54	14.91	10.07	11.09	21.94
Net Income, 5 Yr. CAGR %	18.22	14.53	9.78	10.98	21.91
Normalized Net Income, 5 Yr. CAGR %	13.31	7.92	7.77	12.43	23.5
Diluted EPS Before Extra, 5 Yr. CAGR %	17.43	13.67	9.72	10.77	21.77
Accounts Receivable, 5 Yr. CAGR %	14.19	14.32	11.56	13.88	17.51
Inventory, 5 Yr. CAGR %	26.35	29.93	24.44	20.09	25.06
Net Property, Plant and Equip., 5 Yr. CAGR %	33.6	31.99	34.82	30.31	27.33
Total Assets, 5 Yr. CAGR %	15.88	17.56	14.5	14	12.87
Tangible Book Value, 5 Yr. CAGR %	15.68	18.52	15.19	15.41	13.35
Common Equity, 5 Yr. CAGR %	15.55	18.23	14.78	14.74	12.87
Cash From Operations, 5 Yr. CAGR %	13.96	5.44	9.17	8.61	15.34
Capital Expenditures, 5 Yr. CAGR %	45.67	22.79	41.53	21.16	9.59
Levered Free Cash Flow, 5 Yr. CAGR %	12.95	9.72	1.6	3.19	20.35
Unlevered Free Cash Flow, 5 Yr. CAGR %	12.95	9.72	1.6	3.19	20.35